EU and South Africa conditionally clear GSK/Pfizer
The European Commission has ordered Pfizer to globally divest its ThermaCare brand to proceed with the company’s proposed €10.8 billion joint venture with GlaxoSmithKline, while South Africa’s enforcer also imposed remedies on the deal.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access